Search research articles
Contact Us
Filters
Showing results (101-110 of 111) with videos related to
Page
of 12
Sort By:
Diabetes Technology & Therapeutics
|
May 30, 2023
Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 Sensor
Toni L Cordero, Zheng Dai, Arcelia Arrieta, et al.
Diabetes Technology & Therapeutics
|
March 9, 2022
Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial
Ron Brazg, Satish K Garg, Anuj Bhargava, et al.
Spine
|
December 27, 2023
Gender and Sex Differences in Health-related Quality of Life, Clinical Outcomes and Survival after Treatment of Metastatic Spine Disease
C Rory Goodwin, Meghan Price, Andrea N Goodwin, et al.
Elife
|
April 12, 2022
Effects of mango and mint pod-based e-cigarette aerosol inhalation on inflammatory states of the brain, lung, heart, and colon in mice
Alex Moshensky, Cameron S Brand, Hasan Alhaddad, et al.
Diabetes Technology & Therapeutics
|
October 2, 2023
Safety and Glycemic Outcomes During the MiniMed<sup>TM</sup> Advanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 Diabetes
Catherine Pihoker, Dorothy I Shulman, Gregory P Forlenza, et al.
Diabetes Technology & Therapeutics
|
October 25, 2021
Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes
Anders L Carlson, Jennifer L Sherr, Dorothy I Shulman, et al.
European Journal of Pharmacology
|
December 31, 2013
The preclinical efficacy, selectivity and pharmacologic profile of MK-5932, an insulin-sparing selective glucocorticoid receptor modulator
Philip E Brandish, Kenneth Anderson, Gretchen A Baltus, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2026
Infant gut microbiomes contribute to metabolic states that impact brain function
Firas S Midani, Do-Hun Lee, Younghye Moon, et al.
Diabetes Technology & Therapeutics
|
August 18, 2025
Safety and Glycemic Outcomes of the MiniMed 780G System with a Disposable All-in-One Sensor
Laura M Nally, Jennifer L Sherr, Satish K Garg, et al.
Diabetes Technology & Therapeutics
|
December 6, 2022
Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled Trial
Satish K Garg, George Grunberger, Ruth Weinstock, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 111) with videos related to
Sort By:
Page
of 12
Diabetes Technology & Therapeutics
|
May 30, 2023
Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 Sensor
Toni L Cordero, Zheng Dai, Arcelia Arrieta, et al.
Diabetes Technology & Therapeutics
|
March 9, 2022
Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial
Ron Brazg, Satish K Garg, Anuj Bhargava, et al.
Spine
|
December 27, 2023
Gender and Sex Differences in Health-related Quality of Life, Clinical Outcomes and Survival after Treatment of Metastatic Spine Disease
C Rory Goodwin, Meghan Price, Andrea N Goodwin, et al.
Elife
|
April 12, 2022
Effects of mango and mint pod-based e-cigarette aerosol inhalation on inflammatory states of the brain, lung, heart, and colon in mice
Alex Moshensky, Cameron S Brand, Hasan Alhaddad, et al.
Diabetes Technology & Therapeutics
|
October 2, 2023
Safety and Glycemic Outcomes During the MiniMed<sup>TM</sup> Advanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 Diabetes
Catherine Pihoker, Dorothy I Shulman, Gregory P Forlenza, et al.
Diabetes Technology & Therapeutics
|
October 25, 2021
Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes
Anders L Carlson, Jennifer L Sherr, Dorothy I Shulman, et al.
European Journal of Pharmacology
|
December 31, 2013
The preclinical efficacy, selectivity and pharmacologic profile of MK-5932, an insulin-sparing selective glucocorticoid receptor modulator
Philip E Brandish, Kenneth Anderson, Gretchen A Baltus, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2026
Infant gut microbiomes contribute to metabolic states that impact brain function
Firas S Midani, Do-Hun Lee, Younghye Moon, et al.
Diabetes Technology & Therapeutics
|
August 18, 2025
Safety and Glycemic Outcomes of the MiniMed 780G System with a Disposable All-in-One Sensor
Laura M Nally, Jennifer L Sherr, Satish K Garg, et al.
Diabetes Technology & Therapeutics
|
December 6, 2022
Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled Trial
Satish K Garg, George Grunberger, Ruth Weinstock, et al.
Page
of 12